Consuelo Del Canizo

Consuelo Del Canizo

UNVERIFIED PROFILE

Are you Consuelo Del Canizo?   Register this Author

Register author
Consuelo Del Canizo

Consuelo Del Canizo

Publications by authors named "Consuelo Del Canizo"

Are you Consuelo Del Canizo?   Register this Author

58Publications

2241Reads

13Profile Views

A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts.

Leuk Res 2017 05 4;56:82-87. Epub 2017 Feb 4.

IBMCC, Centro de Investigación del Cáncer, Universidad de Salamanca-CSIC, Spain; IBSAL, Instituto de Investigación Biomédica de Salamanca, Spain; Hospital Universitario de Salamanca, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.01.031DOI Listing
May 2017

Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting.

Eur J Haematol 2016 Dec 1;97(6):528-537. Epub 2016 Jun 1.

Servicio de Hematología, Hospital Universitario de Salamanca - Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12765DOI Listing
December 2016

Insights into the human mesenchymal stromal/stem cell identity through integrative transcriptomic profiling.

BMC Genomics 2016 Nov 21;17(1):944. Epub 2016 Nov 21.

Bioinformatics and Functional Genomics Group, Cancer Research Center (IBMCC, CSIC/USAL) and IBSAL, Consejo Superior de Investigaciones Cientificas (CSIC), Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12864-016-3230-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117530PMC
November 2016

Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents.

J Clin Oncol 2016 09 27;34(25):2988-96. Epub 2016 Jun 27.

Valeria Santini, University of Florence, Florence, Italy; Antonio Almeida, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal; Aristoteles Giagounidis and Stefanie Gröpper, Marien Hospital Düsseldorf; Norbert Gattermann, Heinrich-Heine-Universität, Düsseldorf; Uwe Platzbecker, Technical University Dresden, Dresden, Germany; Anna Jonasova, Charles University General Hospital, Prague, Czech Republic; Norbert Vey, Centre Régional de Lutte Contre le Cancer, Marseille; Pierre Fenaux, Université Paris, Paris, France; Francis Séguy and Albert Hoenekopp, Celgene International, Boudry, Switzerland; Ghulam J. Mufti, King's College Hospital, London, United Kingdom; Rena Buckstein, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Moshe Mittelman and Ron Ram, Tel Aviv University; Ofer Shpilberg, Assuta Medical Center, Tel Aviv, Israel; Consuelo del Cañizo, Hospital Universitario de Salamanca, Salamanca; Alberto Risueño, Celgene Institute for Translational Research Europe, Seville, Spain; Keiya Ozawa, The University of Tokyo, Tokyo, Japan; Kyle J. MacBeth, Celgene Corporation, San Francisco, CA; and Jianhua Zhong and C.L. Beach, Celgene Corporation, Summit, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.0118DOI Listing
September 2016

Do endothelial cells belong to the primitive stem leukemic clone in CML? Role of extracellular vesicles.

Leuk Res 2015 Aug 11;39(8):921-4. Epub 2015 Jun 11.

Servicio de Hematología, IBSAL-Hospital Universitario de Salamanca, Spain; Centro de Investigación del Cáncer, Universidad de Salamanca, Spain; Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2015.05.014DOI Listing
August 2015

Profound blockade of T cell activation requires concomitant inhibition of different class I PI3K isoforms.

Immunol Res 2015 Jun;62(2):175-88

Servicio de Hematología, Hospital Universitario de Salamanca/Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, s/n., 37007, Salamanca, Spain,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12026-015-8648-yDOI Listing
June 2015

Transcriptomic portrait of human Mesenchymal Stromal/Stem Cells isolated from bone marrow and placenta.

BMC Genomics 2014 Oct 19;15:910. Epub 2014 Oct 19.

Bioinformatics and Functional Genomics Group, Cancer Research Center (IBMCC, CSIC/USAL/IBSAL), Consejo Superior de Investigaciones Cientificas (CSIC), Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-15-910DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287589PMC
October 2014

NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.

Clin Cancer Res 2014 Aug 15;20(15):4014-25. Epub 2014 May 15.

Department of Biochemistry and Molecular Biology, University of Salamanca; Instituto de Investigación Biomédica de Salamanca (IBSAL);

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3044DOI Listing
August 2014

Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.

Haematologica 2014 Jul 11;99(7):1168-75. Epub 2014 Apr 11.

Josep Carreras Leukemia Research Institute, Cell Therapy Program of the University of Barcelona, Faculty of Medicine, Barcelona, Spain Instituciò Catalana de Reserca i Estudis Avançats (ICREA), Barcellona, Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.103580DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077077PMC
July 2014

Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeutics.

World J Stem Cells 2014 Jul;6(3):322-43

Antonio Garcia-Gomez, Fermin Sanchez-Guijo, Jesus F San Miguel, Mercedes Garayoa, Cancer Research Center, IBMCC (University of Salamanca-CSIC), 37007 Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4252/wjsc.v6.i3.322DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131274PMC
July 2014

[Myelodysplastic syndrome in the elderly: comprehensive geriatric assessment and therapeutic recommendations].

Med Clin (Barc) 2012 Feb 26;138(3):119.e1-9. Epub 2011 Oct 26.

Servicio de Geriatría, Hospital Universitario La Paz, Madrid, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2011.08.003DOI Listing
February 2012

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.

Haematologica 2011 Jul 10;96(7):1072-6. Epub 2011 Mar 10.

Servicio de Hematología, Instituto de Biomedicina de Sevilla (IBIS) Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Avenida Manuel Siurot s/n 41013 Sevilla, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2010.038356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128230PMC
July 2011

Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.

Leuk Res 2011 Jun 26;35(6):834-6. Epub 2011 Jan 26.

Department of Pathology, Hospital del Mar, GRETNHE, IMIM (Hospital del Mar Research Institute), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.01.003DOI Listing
June 2011

Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements.

Ann Hematol 2010 Feb 19;89(2):147-54. Epub 2009 Aug 19.

Hematology Department, Centro Hospitalario de Toledo, Avenida Barber, 30., 45004, Toledo, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-009-0794-7DOI Listing
February 2010

Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.

Transfusion 2009 Sep 20;49(9):1901-10. Epub 2009 May 20.

Hematology, Cell Therapy Area and Immunology Service, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2009.02226.xDOI Listing
September 2009

A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.

Haematologica 2008 Mar 11;93(3):405-12. Epub 2008 Feb 11.

Department of Hematology, Nottingham University Hospitals NHS Trust (City Campus), Nottingham NG5 1PB, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.11287DOI Listing
March 2008

Launching a clinical program of stem cell therapy for cardiovascular repair.

Nat Clin Pract Cardiovasc Med 2007 Feb;4 Suppl 1:S123-9

Research Program at Cardiology Service, Hospital Universitario Gregorio Marañón, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpcardio0767DOI Listing
February 2007

Immunophenotypic analysis of myelodysplastic syndromes.

Haematologica 2003 Apr;88(4):402-7

Servicio de Hematología, Hospital Universitario de Salamanca, Paseo San Vicente 58-182, 3700 Salamanca, Spain.

View Article

Download full-text PDF

Source
April 2003

[Long-term culture: evidence of the capacity of stroma to sustain hematopoiesis of a second inoculum].

Sangre (Barc) 1996 Oct;41(5):345-9

Servicio de Hematología y Hemoterapia, Hospital Clínico Universitario de Salamanca.

View Article

Download full-text PDF

Source
October 1996